Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 38.91
0.569 %
$ 2.15 B
Market Cap
36.36
P/E
SUPN - LONG-TERM DEBT
Long-term Debt SUPN - Supernus Pharmaceuticals, Inc.
33.2 M
LAST VALUE
-71.90%
2 YEAR CAGR
-36.81%
5 YEAR CAGR
-0.35%
10 YEAR CAGR